From Proteomic Analysis to Potential Therapeutic Targets: Functional Profile of Two Lung Cancer Cell Lines, A549 and SW900, Widely Studied in Pre-Clinical Research

• Luís Korrodi-Gregório,

  Affiliations Cancer Cell Biology Research Group, Department of Pathology and Experimental Therapeutics, Faculty of Medicine, University of Barcelona, Campus Bellvitge, Feixa Llarga s/n, 08907, L'Hospitalet de Llobregat, Spain, Laboratory of Signal Transduction, Department of Medical Sciences, Institute for Research in Biomedicine—iBiMED, Health Sciences Program, University of Aveiro, Campus de Santiago, 3810–193, Aveiro, Portugal

  http://orcid.org/0000-0002-2811-8081

  ⨯
• Vanessa Soto-Cerrato,

  Affiliation Cancer Cell Biology Research Group, Department of Pathology and Experimental Therapeutics, Faculty of Medicine, University of Barcelona, Campus Bellvitge, Feixa Llarga s/n, 08907, L'Hospitalet de Llobregat, Spain

  ⨯
• Rui Vitorino,

  Affiliations Department of Medical Sciences, Institute for Research in Biomedicine—iBiMED, Health Sciences Program, University of Aveiro, Campus de Santiago, 3810–193, Aveiro, Portugal, Department of Physiology and Cardiothoracic Surgery, Faculty of Medicine, University of Porto, Alameda Professor Hernâni Monteiro, 4200–319, Porto, Portugal

  ⨯
• Margarida Fardilha ,

  * E-mail: rperez@ub.edu (RPT); mfardilha@ua.pt (MF)

  Affiliation Laboratory of Signal Transduction, Department of Medical Sciences, Institute for Research in Biomedicine—iBiMED, Health Sciences Program, University of Aveiro, Campus de Santiago, 3810–193, Aveiro, Portugal

  ⨯
• Ricardo Pérez-Tomás

  * E-mail: rperez@ub.edu (RPT); mfardilha@ua.pt (MF)

  Affiliation Cancer Cell Biology Research Group, Department of Pathology and Experimental Therapeutics, Faculty of Medicine, University of Barcelona, Campus Bellvitge, Feixa Llarga s/n, 08907, L'Hospitalet de Llobregat, Spain

  ⨯